Viewing Study NCT03455504


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2025-12-25 @ 5:32 PM
Study NCT ID: NCT03455504
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-10
First Post: 2018-02-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module